Clinical Trial Update: A Study Conducted in Healthy Subjects to Demonstrate Bioequivalence Between Ropinirole Prolonged Release Tablets Manufactured at Crawley and Aranda [Phase 1]

View source ↗

Summary

A Phase 1 study in healthy subjects demonstrated bioequivalence between ropinirole prolonged-release tablets manufactured at Crawley and Aranda, sponsored by Gl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Ropinirole prolonged-release tablets (ropinirole)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Parkinson Disease | Phase 1 | Status: COMPLETED